Certara Partners With Thomson Reuters to Expand Data Access Through Its D360 Drug Discovery and Development Platform

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that it is partnering with Thomson Reuters to provide its customers with access to Thomson Reuters Cortellis™ for Informatics life sciences content through its D360™ platform. Certara’s D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC